4/A//SEC Filing
Bengtsson Carl Martin 4/A
Accession 0001140361-25-013555
CIK 0000009326other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 6:15 PM ET
Size
11.1 KB
Accession
0001140361-25-013555
Insider Transaction Report
Form 4/AAmended
BALCHEM CORPBCPC
Bengtsson Carl Martin
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-12+2,360→ 20,528 total - Award
Common Stock
2025-02-13+5,432→ 25,960 total - Tax Payment
Common Stock
2025-02-13$163.14/sh−2,781$453,692→ 23,179 total - Award
Stock Option
2025-02-12+7,700→ 7,700 totalExercise: $159.18Exp: 2035-02-12→ Common Stock (7,700 underlying)
Holdings
- 952(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Ownership of restricted stock vests in Reporting Person ratably over a 3 year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
- [F2]Represents the vesting of performance stock units (includes 89 dividend equivalent shares) for the 2022-2024 performance period.
- [F3]2,781 of the 5,432 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
- [F4]Options vest 20% Year 1; 40% Year 2: and 40% Year 3.
Documents
Issuer
BALCHEM CORP
CIK 0000009326
Entity typeother
Related Parties
1- filerCIK 0001766386
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 6:15 PM ET
- Size
- 11.1 KB